Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis

Author： Lai Gillianne Geet Yi   Koo Yu Xuan   Tao Miriam   Tan Thuan Tong   Lim Soon-Thye  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.50, Iss.1, 2011-01, pp. : 144-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy

By Kinoshita Manabu   Hashimoto Naoya   Izumoto Shuichi   Okita Yoshiko   Kagawa Naoki   Maruno Motohiko   Ohnishi Takanori   Arita Norio   Yoshimine Toshiki  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma

By Campen Christopher   Tombleson Rebecca   Green Myke  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 345-355

Springer Publishing Company

Access to resources Recommend Favorite

High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder

By Patrick A.   Wee A.   Hedderman A.   Wilson D.   Weiss J.   Govani M.  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 739-743

Springer Publishing Company

Access to resources Recommend Favorite

Systemic high-dose intravenous methotrexate for central nervous system metastases

By Lassman Andrew   Abrey Lauren   Shah Gaurav   Panageas Katherine   Begemann Martin   Malkin Mark   Raizer Jeffrey  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

Systemic high-dose intravenous methotrexate for central nervous system metastases

By Lassman Andrew   Abrey Lauren   Shah Gaurav   Panageas Katherine   Begemann Martin   Malkin Mark   Raizer Jeffrey  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 261-261

Springer Publishing Company

Access to resources Recommend Favorite